Surge protector: A novel approach to suppressing therapy-induced tumor growth and recurrence
BOSTON - Following up on a groundbreaking 2018 study in which BIDMC's Dipak Panigrahy, MD, demonstrated that dead and dying ...
Tag: cancer
Why haven't cancer cells undergone genetic meltdowns?
Cancer first develops as a single cell going rogue, with mutations that trigger aggressive growth at all costs to the ...
Study of mutation order may change understanding of how tumors develop
Cancer Cell paper envisions new direction in cancer research Cancers most commonly arise because of a series of two to ...
How cancer becomes transmissible in Tasmanian devils: Molecular mechanisms elucidated
Credit: Kosack et al., 2019, Cancer Cell 35, 1-5, January 14, 2019 © 2018 Published by Elsevier Inc. DOI: 10.1016/j.ccell.2018.11.018. ...
Hindering melanoma metastasis with an FDA-approved drug
Promising findings from the School of Veterinary Medicine show that a medicine originally used to control blood pressure may prevent ...
Suicide risk more than quadruples for people with cancer
Hershey, Pa -- People with cancer are more than four times more likely to commit suicide than people without cancer, ...
Nebraska leads $11 million study to develop radiation exposure drugs
Credit: Craig Chandler | University of Nebraska-Lincoln The U.S. Department of Defense has turned to the University of Nebraska to ...
Fort McMurray homes have normal levels of indoor toxins, U of T Engineering study reveals
In the aftermath of the Fort McMurray wildfire, chemical engineering professor Arthur Chan and his team reveal results from dust ...
In breast-cancer prevention, race matters
Study: Black women face additional obstacles to information, receive less preventive careCredit: The Ohio State University COLUMBUS, Ohio - African-American ...
Researchers discover common markers of tumor hypoxia across 19 cancer types
Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumors TORONTO (January 14, 2019) - Unlike ...
Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated
Study underscores importance of sharing risks with patients considering lung cancer screeningCredit: MD Anderson Cancer Center HOUSTON - Complication rates ...
TGF-beta pathway protects against uterine cancer
Credit: Baylor College of Medicine Two new mouse models of uterine cancer shed light on how this disease - the ...
Anticancer drug candidate inhibits lethal aggregation of mutant tumor suppressor protein
Brazilian researchers are the first to demonstrate the action of PRIMA-1 against amyloid aggregates of mutant p53 protein, structure found ...
More accurate leukemia diagnosis expected as researchers refine leukemia classification
Research led by St. Jude Children's Research Hospital means more than 90 percent of the most common cases of childhood ...
Antihypertension drug losartan may improve treatment of ovarian cancer
Mass. General study also identifies potential biomarker for chemotherapy response, resistance A new study from a Massachusetts General Hospital (MGH) ...
Scientists identify gene contributing to prostate cancer drug resistance
The GREB1 gene promotes resistance to prostate cancer treatments, making it a potential target for future therapies Researchers have discovered ...
Herpes viruses and tumors evolved to learn how to manipulate the same ancient RNA
Findings could have implications for drugs and insight into diseases like Alzheimer's (New York, NY - January 14, 2019) -- ...
Purchase receipts with easily erasable ink contain cancer-infertility inducing substances
Credit: University of Granada BPA is a well-known endocrine disruptor that alters hormonal balance in people exposed to it, and ...
Personalized treatment benefits kidney cancer patients
Credit: Radiological Society of North America OAK BROOK, Ill. - Personalized treatment plans may extend life expectancy for early-stage kidney ...
Gene-editing tool CRISPR/Cas9 shown to limit impact of certain parasitic diseases
GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter ...
